Australia · Delayed Price · Currency is AUD NeuRizer Statistics
Total Valuation
NeuRizer has a market cap or net worth of AUD 3.36 million. The enterprise value is 4.90 million.
| Market Cap | 3.36M |
| Enterprise Value | 4.90M |
Important Dates
The last earnings date was Monday, March 2, 2026.
| Earnings Date | Mar 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NeuRizer has 3.36 billion shares outstanding.
| Current Share Class | 3.36B |
| Shares Outstanding | 3.36B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +44.38% |
| Owned by Insiders (%) | 6.49% |
| Owned by Institutions (%) | 0.85% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.05 |
| P/TBV Ratio | 0.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.62 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.17 |
Financial Position
The company has a current ratio of 0.00, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.41 |
| Interest Coverage | -2.45 |
Financial Efficiency
Return on equity (ROE) is -10.69% and return on invested capital (ROIC) is -3.05%.
| Return on Equity (ROE) | -10.69% |
| Return on Assets (ROA) | -1.75% |
| Return on Invested Capital (ROIC) | -3.05% |
| Return on Capital Employed (ROCE) | -4.97% |
| Weighted Average Cost of Capital (WACC) | 25.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -786,570 |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.43% in the last 52 weeks. The beta is -0.24, so NeuRizer's price volatility has been lower than the market average.
| Beta (5Y) | -0.24 |
| 52-Week Price Change | -71.43% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 40.95 |
| Average Volume (20 Days) | 7,375,554 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.64M |
| Pretax Income | -7.87M |
| Net Income | -7.87M |
| EBITDA | -3.60M |
| EBIT | -3.64M |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 128,454 in cash and 1.72 million in debt, with a net cash position of -1.59 million or -0.00 per share.
| Cash & Cash Equivalents | 128,454 |
| Total Debt | 1.72M |
| Net Cash | -1.59M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 72.08M |
| Book Value Per Share | 0.02 |
| Working Capital | -59.24M |
Cash Flow
In the last 12 months, operating cash flow was -2.68 million and capital expenditures -1.51 million, giving a free cash flow of -4.19 million.
| Operating Cash Flow | -2.68M |
| Capital Expenditures | -1.51M |
| Depreciation & Amortization | 42,821 |
| Net Borrowing | 1.62M |
| Free Cash Flow | -4.19M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NeuRizer does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.68% |
| Shareholder Yield | -62.68% |
| Earnings Yield | -234.24% |
| FCF Yield | -124.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |